Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent L Chen

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Hepatology (Baltimore, Md.)|October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 31, 2021
What patients with eosinophilic esophagitis may not share with their providers: a qualitative assessment of online health communitiesJoy W Chang, Vincent L Chen, Joel H Rubenstein, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Reply: AASLD Resmetirom GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 23, 2025
Prevalence and clinical outcomes of recompensation in decompensated cirrhosis: a systematic review and meta-analysisXin En Goh, May Xuan Goh, Vincent L Chen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 4, 2021
Phenotyping patients with borderline elevated esophageal acid exposureChanakyaram A Reddy, Kevin Wenzke, Lydia S Watts, et al.
Hepatology Communications|June 2, 2023
Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with ageMatthew J Miller, Emily Harding-Theobald, Jacob V DiBattista, et al.
The Journal of Clinical Investigation|April 1, 2025
Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatmentVincent L Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Hepatology|April 6, 2024
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohortVincent L Chen, Xiaomeng Du, Antonino Oliveri, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbiditiesKarn Wijarnpreecha, Fang Li, Sori K Lundin, et al.
Hepatology Communications|January 24, 2022
A Dual-Filtration System for Single-Cell Sequencing of Circulating Tumor Cells and Clusters in HCCVincent L Chen, Qianhui Huang, Ramdane Harouaka, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 31, 2021
What patients with eosinophilic esophagitis may not share with their providers: a qualitative assessment of online health communitiesJoy W Chang, Vincent L Chen, Joel H Rubenstein, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Reply: AASLD Resmetirom GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 23, 2025
Prevalence and clinical outcomes of recompensation in decompensated cirrhosis: a systematic review and meta-analysisXin En Goh, May Xuan Goh, Vincent L Chen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 4, 2021
Phenotyping patients with borderline elevated esophageal acid exposureChanakyaram A Reddy, Kevin Wenzke, Lydia S Watts, et al.
Hepatology Communications|June 2, 2023
Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with ageMatthew J Miller, Emily Harding-Theobald, Jacob V DiBattista, et al.
The Journal of Clinical Investigation|April 1, 2025
Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatmentVincent L Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Hepatology|April 6, 2024
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohortVincent L Chen, Xiaomeng Du, Antonino Oliveri, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbiditiesKarn Wijarnpreecha, Fang Li, Sori K Lundin, et al.
Hepatology Communications|January 24, 2022
A Dual-Filtration System for Single-Cell Sequencing of Circulating Tumor Cells and Clusters in HCCVincent L Chen, Qianhui Huang, Ramdane Harouaka, et al.
Pageof 13